Drug Type Natural Killer Cell Therapies |
Synonyms HC 101, HC 101a, HC-101 + [2] |
Target- |
Action- |
Mechanism- |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhaseIND Approval |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Recurrent Ewing Sarcoma | IND Approval | United States | 25 Jun 2026 | |
| Recurrent Ewing Sarcoma | IND Approval | United States | 25 Jun 2026 | |
| Refractory Ewing Sarcoma | IND Approval | United States | 25 Jun 2026 | |
| Refractory Ewing Sarcoma | IND Approval | United States | 25 Jun 2026 |





